NO20062918L - Anvendelse av antibiotika som vaksineadjuvanser - Google Patents

Anvendelse av antibiotika som vaksineadjuvanser

Info

Publication number
NO20062918L
NO20062918L NO20062918A NO20062918A NO20062918L NO 20062918 L NO20062918 L NO 20062918L NO 20062918 A NO20062918 A NO 20062918A NO 20062918 A NO20062918 A NO 20062918A NO 20062918 L NO20062918 L NO 20062918L
Authority
NO
Norway
Prior art keywords
adjuvant
azalide
vaccine
antibiotics
antimicrobial agent
Prior art date
Application number
NO20062918A
Other languages
English (en)
Norwegian (no)
Inventor
Michael K O'hara
David Ross Mcgavin
Randy Dean Leyh
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO20062918L publication Critical patent/NO20062918L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/116—Polyvalent bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20062918A 2003-11-21 2006-06-21 Anvendelse av antibiotika som vaksineadjuvanser NO20062918L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52409703P 2003-11-21 2003-11-21
PCT/IB2004/003694 WO2005049081A1 (en) 2003-11-21 2004-11-08 The use of anti biotics as vaccine adjuvants

Publications (1)

Publication Number Publication Date
NO20062918L true NO20062918L (no) 2006-08-21

Family

ID=34619630

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20062918A NO20062918L (no) 2003-11-21 2006-06-21 Anvendelse av antibiotika som vaksineadjuvanser

Country Status (16)

Country Link
US (1) US20070141086A1 (pt)
EP (1) EP1689434A1 (pt)
JP (1) JP2007512312A (pt)
KR (1) KR100785601B1 (pt)
CN (1) CN1882360A (pt)
AR (1) AR047728A1 (pt)
AU (1) AU2004290982B2 (pt)
BR (1) BRPI0416205A (pt)
CA (1) CA2546195A1 (pt)
IL (1) IL175373A0 (pt)
MX (1) MXPA06005639A (pt)
NO (1) NO20062918L (pt)
RU (1) RU2322241C2 (pt)
TW (1) TW200526245A (pt)
WO (1) WO2005049081A1 (pt)
ZA (1) ZA200603065B (pt)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070077256A1 (en) 1999-11-19 2007-04-05 Los Angeles Biomedical Research Institute Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis and other infectious agents
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
ES2532906T5 (es) 2002-10-25 2022-03-23 Foamix Pharmaceuticals Ltd Espuma cosmética y farmacéutica
FR2896416B1 (fr) * 2006-01-24 2010-08-13 Vetoquinol Composition anti-infectieuse comprenant un compose de type pyrido (3,2,1-ij)-benzoxadiazine
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
WO2009090495A2 (en) 2007-12-07 2009-07-23 Foamix Ltd. Oil and liquid silicone foamable carriers and formulations
BRPI0822098A2 (pt) * 2007-12-21 2015-06-30 Glaxosmithkline Biolog Sa Componente para uma vacina contra malária, vacina para malária, processo para a preparação do componente, uso do componente, e, método de tratar um paciente suscetível às infecções por plasmodium
WO2010125470A2 (en) 2009-04-28 2010-11-04 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
CA2769625C (en) 2009-07-29 2017-04-11 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013008A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
EP2482788B1 (en) 2009-10-02 2022-12-14 Journey Medical Corporation Topical tetracycline compositions
EP2528620B1 (en) * 2010-01-28 2019-06-05 Universiteit Gent Salmonella vaccine
WO2013015831A1 (en) * 2011-07-22 2013-01-31 Novadigm Therapeutics, Inc. Methods and compositions for vaccinating against staphylococcus aureus
HK1220389A1 (zh) * 2013-03-14 2017-05-05 Wang Rongfu 调控调节性t细胞功能的方法和组合物
AU2014227748B2 (en) 2013-03-15 2019-02-14 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Compositions and methods for treating fungal and bacterial pathogens
CN103127098B (zh) * 2013-03-22 2014-05-14 于法周 一种含有克拉维酸或其盐的抗癌药物组合物及制药用途
EP2926815A1 (en) * 2014-04-03 2015-10-07 Institut Curie New derivatives of cephalosporin for treating cancer
CN105616414B (zh) * 2014-10-28 2019-03-05 湘北威尔曼制药股份有限公司 一种氧代哌嗪酰胺类化合物的新用途
WO2016065525A1 (zh) * 2014-10-28 2016-05-06 湘北威尔曼制药股份有限公司 一种氧代哌嗪酰胺类化合物的用途
CN104546863B (zh) * 2015-02-09 2016-09-14 江苏澳格姆生物科技有限公司 头孢噻吩钠在制备抑制肿瘤细胞转移和扩散的药物中的应用
CN107847602A (zh) * 2015-08-06 2018-03-27 日东电工株式会社 免疫诱导促进组合物和疫苗药物组合物
WO2017116049A1 (ko) * 2015-12-31 2017-07-06 경북대학교 산학협력단 설폰아마이드계 화합물을 유효성분으로 포함하는 암의 치료 및 전이 억제용 약학적 조성물
WO2017155949A1 (en) 2016-03-09 2017-09-14 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Methods and kits for use in preventing and treating vulvovaginal candidiasis
CA2978573A1 (en) 2016-09-08 2018-03-08 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne
CN110302376A (zh) * 2019-04-22 2019-10-08 荆门市动物疫病预防控制中心 一种禽流感疫苗佐剂及应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69619894T2 (de) * 1995-06-30 2002-11-14 American Cyanamid Co., Madison Stabile Makrolide und Makrolide Imptstoff-Zusammensetzungen
US5929086A (en) * 1996-05-10 1999-07-27 Pharmacia & Upjohn Company Topical administration of antimicrobial agents for the treatment of systemic bacterial diseases
HN1998000086A (es) * 1997-06-11 1999-03-08 Pfizer Prod Inc Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
US6339063B1 (en) * 1997-09-10 2002-01-15 Merck & Co., Inc. 9a-azalides as veterinary antimicrobial agents
UA70972C2 (uk) * 1998-11-20 2004-11-15 Пфайзер Продактс Інк. 13-членні азаліди і їх застосування як антибіотиків

Also Published As

Publication number Publication date
CA2546195A1 (en) 2005-06-02
KR20060091001A (ko) 2006-08-17
EP1689434A1 (en) 2006-08-16
RU2322241C2 (ru) 2008-04-20
WO2005049081A1 (en) 2005-06-02
RU2006117339A (ru) 2007-12-10
BRPI0416205A (pt) 2006-12-26
ZA200603065B (en) 2007-08-29
AU2004290982B2 (en) 2008-06-19
JP2007512312A (ja) 2007-05-17
AR047728A1 (es) 2006-02-15
CN1882360A (zh) 2006-12-20
IL175373A0 (en) 2006-09-05
KR100785601B1 (ko) 2007-12-14
MXPA06005639A (es) 2006-08-17
US20070141086A1 (en) 2007-06-21
AU2004290982A1 (en) 2005-06-02
TW200526245A (en) 2005-08-16

Similar Documents

Publication Publication Date Title
MXPA06005639A (es) Adyuvante antimicrobiano.
BRPI0410503B8 (pt) composição tópica e uso da composição
NO20061912L (no) Vaksinesammensetninger omfattende et interleukin 18 og saponin adjuvant system
DK1187629T3 (da) Adjuvanssammensætning omfattende saponin og et immunostimulerende oligonucleotid
WO2004087153A3 (en) Use of organic compounds for immunopotentiation
SE0102315D0 (sv) Compounds
NO20063479L (no) Fosfonater, monofosfonamidater og bis-fosfonamidater for behandling av virussykdommer
CU23366B7 (es) Oxazolidinonas substituidas para terapia de combinación
TR200400363T4 (tr) Antibiyotikten / Antibiyotiklerden oluşan bir preparatın imalatı ve kullanımı
CY1108808T1 (el) Ενωσεις μοτιλιδης
WO2003096989A3 (en) Anti tubercular drug: compositions and methods
AR109263A2 (es) Composición que comprende moxidectina
EA200600280A1 (ru) Композиции на основе производных липопептидных антибиотиков и способы их применения
CL2013002106A1 (es) Composicion inmunogenica de streptococcus pneumoniae que comprende 2 o mas conjugados de sacarido capsular de diferentes serotipos; vacuna que la comprende; procedimiento de fabricacion; y su uso para tratar o prevenir enfermedades causadas por la infeccion por streptococcus pneumoniae (div.sol.n°3625-2006).
NO20061911L (no) Immunogene sammensetninger
NO20044658L (no) Anvendelse av osteoprotegerin til behandling og/eller forhindring av fibrotiske sykdommer
EA200300948A1 (ru) Водная композиция амфотерицина b
CR7195A (es) Nuevos derivados de oxazolidinonas como antibacterianos
ECSP045397A (es) 6-ALQUILIDEN-PENEMS BICÍCLICOS COMO INHIBIDORES DE LAS b-LACTAMASAS
UY28313A1 (es) Nonadepsipeptidos acilados
UY28542A1 (es) Amidas macrocíclicas antibacterianas
CR9073A (es) Coadministracion de tigeciclina y digoxin
ECSP045405A (es) Penems 6-alquiliden heterotriciclil como inhibidores de la beta lactamasa
AR053775A1 (es) Nonadepsipeptidos acilados ii
BR9911944A (pt) Proteìna inibidora da quimiotaxia do staphylococcus (proteìna chips) e sua utilização

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application